AstraZeneca itself is building an arsenal of anti-cancer pills known as tyrosine kinase inhibitors.

FORBES: Cancer Drugs A Key In MedImmune Purchase

By 1999 Zeneca had devised a drug, Iressa, that interrupted the pathways between EGF and tyrosine kinase.

FORBES: The World's Billionaires

When EGF docks on a receptor, it signals to an enzyme called tyrosine kinase to regulate cell growth.

FORBES: Modesty ablaze